Wang Ya-Fang, Chang CF, Tsai HP, Chi CY, Su IJ, Wang JR*. Glycan-Binding Preferences and Genetic Evolution of Human
Seasonal Influenza A(H3N2) Viruses during 1999-2007 in Taiwan. PLoS One. 2018 (Accepted)
Wang Ya-Fang, Shen FC, Wang SL, Kuo PH, Tsai HP, Liu CC, Wang JR, Chi CY*. Molecular Epidemiology and Clinical Manifestations
of Adenovirus Respiratory Infections in Taiwanese Children. Medicine (Baltimore). 2016 May;95(18):e3577. doi: 10.1097/MD.0000000000003577.
Lim M. C.Y., † Wang Ya-Fang, † Huang S. W., Yang J. Y., Wang J. R.*. High incidence of mammalian orthoreovirus
identified by environmental surveillance in Taiwan. Microbes and Environments. PLoS One. 2015 Nov 10;10(11):e0142745.
Chia MY, Hu AY, Tseng YF, Weng TC, Lai CC, Lin JY, Chen PL, Wang Ya-Fang, Chao SR, Chang JY, Hwang YS, Yeh CT, Yu CP,
Chen YC, Su IJ, Lee MS*. Evaluation of MDCK Cell-Derived Influenza H7N9 Vaccine Candidates in Ferrets. PLoS One. 2015
Mar 23;10(3):e0120793.
Lee PH, Liu CM, Ho TS, Tsai YC, Lin CC, Wang Ya-Fang, Chen YL, Yu CK, Wang SM, Liu CC, Shiau AL, Lei HY, Chang CP*.
Enterovirus 71 virion-associated galectin-1 facilitates viral replication and stability. PLoS One. 2015 Feb 23;10(2):e0116278.
Su PY, Wang Ya-Fang, Huang SW, Lo YC, Wang YH, Wu SR, Shieh DB, Chen SH, Wang JR, Lai MD, Chang CF*. Cell surface nucleolin
facilitates enterovirus 71 binding and infection. J Virol. 2015 Apr 15;89(8):4527-38.
Wang Ya-Fang, Yu CK*. Animal models of enterovirus 71 infection: applications and limitations. J Biomed Sci. 2014 Apr
17;21:31. Review.
Linsuwanon P, Puenpa J, Huang SW, Wang Ya-Fang, Mauleekoonphairoj J, Wang JR, Poovorawan Y*. Epidemiology and seroepidemiology
of human enterovirus 71 among Thai populations. J Biomed Sci. 2014 Feb 18;21:16.
Chou AH, Liu CC, Chang JY, Jiang R, Hsieh YC, Tsao A, Wu CL, Huang JL, Fung CP, Hsieh SM, Wang Ya-Fang, Wang JR, Hu
MH, Chiang JR, Su IJ, Chong PC*. Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against
subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS One. 2013 Nov 21;8(11):e79783.
Hung CH, Yang SN, Wang Ya-Fang, Liao WT, Kuo PL, Tsai EM, Lee CL, Chao YS, Yu HS, Huang SK, Suen JL*. Environmental
alkylphenols modulate cytokine expression in plasmacytoid dendritic cells. PLoS One. 2013 Sep 11;8(9):e73534.
Thoa le PK, Chiang PS, Khanh TH, Luo ST, Dan TN, Wang Ya-Fang, Thuong TC, Chung WY, Hung NT, Wang JR, Nhan le NT, Thinh
le Q, Su IJ, Dung TD, Lee MS*. Genetic and antigenic characterization of enterovirus 71 in Ho Chi Minh City, Vietnam,
2011. PLoS One. 2013 Jul 29;8(7):e69895.
Lee YP, Wang Ya-Fang, Wang JR, Huang SW, Yu CK*. Enterovirus 71 blocks selectively type I interferon production through
the 3C viral protein in mice. J Med Virol. 2012 Nov;84(11):1779-89.
Liu Y. T., P. Y. Su, H. Y. Chang, S. W. Huang, Wang Ya-Fang, C. K. Yu, J. R.Wang and C. F. Chang*. Cell surface sialylation
affects binding of Enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells. BMC Microbiology. 2012. Aug 1;12:162.
Wang Ya-Fang, C. F. Chang, C. Y. Chi, H. C. Wang, J. R. Wang, I. J. Su*. Characterization of glycan binding specificities
of Influenza B viruses with correlation with hemagglutinin genotypes and clinical features. J Med Virol. 2012 Apr;84(4):679-85.
Wang Ya-Fang, W. I. Lao, Y. D. Kuo1, S. Y. Guu, H. C. Wang, C. H. Lin, J. R. Wang, I. J. Su, C. F Chang*. Receptor
binding surveillance of influenza clinical isolates. Future Virol 2012; 7(6): 621-633.
Huang, S. W., Wang Ya-Fang, C. K. Yu, I. J. Su, J. R. Wang*. Mutations in VP2 and VP1 capsid proteins increase infectivity
and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology 2012 Jan 5;422(1):132-43.
Lao, W. I., Wang Ya-Fang, Y. D. Kuo, C. H. Lin, T. C. Chang, I. J. Su, J. R. Wang, C. F. Chang*. Profiling of influenza
viruses by high-throughput carbohydrate membrane array. Fut Med Chem. 2011; 3:283-296.
Chen, C.W., Y. P. Lee, Wang Ya-Fang, and C. K. Yu*. Formaldehyde-inactivated human enterovirus 71 vaccine is compatible
for co-immunization with a commercial pentavalent vaccine. Vaccine. 2011; 29:2772-2776.
Wong, T. W., H. J. Huang, Wang Ya-Fang, Y. P. Lee, C. C. Huang, and C. K. Yu*. Methylene blue-mediated photodynamic
inactivation as a novel disinfectant of enterovirus 71. J Antimicrob Chemother 2010, 65:2176-82.
Chen, C. S., Y. C. Yao, S. C. Lin, Y. P. Lee, Wang Ya-Fang, J. R. Wang, C. C. Liu, H. Y. Lei, and C. K. Yu*. Retrograde
axonal transport: the major transmission route of enterovirus 71 in mice. J Virol 2007, 81:8996-9003.
Wu, T. C., Wang Ya-Fang, Y. P. Lee, J. R. Wang, C. C. Liu, S. M. Wang, H. Y. Lei, I. J. Su, and C. K. Yu*. Immunity
to avirulent enterovirus 71 and Coxackie A16 virus protect enterovirus 71 infection in mice. J Virol 2007, 81:10310-10315.
Liu, M.L., Y. P. Lee, Wang Ya-Fang, H. Y. Lei, C. C. Liu, S. M. Wang, I. J. Su, J. R. Wang, T. M. Yeh, S. H. Chen,
and C. K. Yu. 2005 Type I interferons protect mice against enterovirus 71 infection. J Gen Virol: 86, 3263-3269.
Wang Ya-Fang, C. T. Chou, H. Y. Lei, C. C. Liu, S. M. Wang, J. J. Yan, I. J. Su, J. R. Wang, T. M. Yeh, S. H. Chen,
and C. K. Yu. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection.
J Virol 78:7916-24.
Chen, Y. C., C. K. Yu, Wang Ya-Fang, C.C. Liu, I.J. Su and H.Y. Lei. 2004 A murine oral enterovirus 71 infection model
with central nervous system involvement. J Gen Virol 85: 69–77.
Ya-Fang Wang, Sheng-Wen Huang, Piyada Linsuwanon, Yoke-Fun Chan, Yong Poovorawan and Jen-Ren Wang. Antigenic Variations
among Enterovirus 71 Genotypes by Using Human Antisera from Different Countries. The 32nd annual meeting of the American
Society for Virology (ASV), 2013, Pennsylvania, U.S.A.
Ya-Fang Wang, Sheng-Wen Huang, Jen-Ren Wang, Huan-Yao Lei, and Chun-Keung Yu. Multiple amino acid variations of enterovirus
71 alter its in vitro phenotypes and virulence in mice during mouse brain adaptation. International Symposium on Infectious
Disease and Signal Transduction-Taiwan-Japan Joint Symposium on Cell Signaling and Gene Regulation-Professor Huan-Yao
Lei Memorial Symposium, 2012, Tainan, Taiwan.
Ya-Fang Wang, Chia-Yu Chi, Chuan-Fa Chang, Hsuan-Chen Wang, Jen-Ren Wang, Ih-Jen Su. Hemagglutinin Receptor Binding
Preferences of Recent Influenza A Viruses in Taiwan. International Society for Influenza and other Respiratory Virus
Diseases: isirv--'Severe Influenza: Burden, Pathogenesis and Management', 2012, Hanoi, Viet Nam.
Ya-Fang Wang, Chia-Yu Chi, Chuan-Fa Chang, Hsuan-Chen Wang, Jen-Ren Wang, Ih-Jen Su. Different receptor binding preference
of influenza A/H3N2 and B viruses correlated with clinical presentations and epidemiology. Keystone symposia on Molecular
and Cellular Biology Pathogenesis of Influenza: Virus-Host Interactions (E3). 2011, Hong Kong, China. (Received Scholarship
award).
Ya-Fang Wang, Chia-Yu Chi, Chuan-Fa Chang, Hsuan-Chen Wang, Jen-Ren Wang, Ih-Jen Su. Exploring the carbohydrate receptor
binding specificity of swine H1N1 and seasonal influenza viruses in Taiwan. Options for Control of Influenza VII,
2010, Hong Kong, China.
Ya-Fang Wang, Chia-Yu Chi, Chuan-Fa Chang, Hsuan-Chen Wang, Jen-Ren Wang, and Ih-Jen Su. Clinical phenotype and glycan
biology of Influenza B in Taiwan. The 3rd International Conference on Influenza Vaccines for the World, 2009, Cannes,
France.